Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy
Autor: | Mariola Sulkowska, Eva Surmacz, Stanislaw Sulkowski, Luiza Kanczuga-Koda, Mariusz Koda |
---|---|
Jazyk: | angličtina |
Předmět: |
Oncology
Adult Leptin medicine.medical_specialty Cancer Research Estrogen receptor Breast Neoplasms lcsh:RC254-282 Breast cancer Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Biomarkers Tumor Genetics Humans Estrogen receptor beta Aged Neoplasm Staging Aged 80 and over Glucose Transporter Type 1 Leptin receptor Tumor hypoxia business.industry Middle Aged medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Hypoxia-Inducible Factor 1 alpha Subunit Metastatic breast cancer Immunohistochemistry Cell Hypoxia Neoadjuvant Therapy Ki-67 Antigen Treatment Outcome Receptors Estrogen Chemotherapy Adjuvant Lymphatic Metastasis Receptors Leptin Female business Estrogen receptor alpha hormones hormone substitutes and hormone antagonists Research Article |
Zdroj: | BMC Cancer BMC Cancer, Vol 10, Iss 1, p 320 (2010) |
ISSN: | 1471-2407 |
DOI: | 10.1186/1471-2407-10-320 |
Popis: | Background Tumor hypoxia is marked by enhanced expression of hypoxia-inducible factor-α (HIF-1α) and glucose transporter-1 (Glut-1). Hypoxic conditions have also been associated with overexpression of angiogenic factors, such as leptin. The aim of our study was to analyze the relationships between hypoxia markers HIF-1α, Glut-1, leptin, leptin receptor (ObR) and other breast cancer biomarkers in primary and metastatic breast cancer in patients treated or untreated with preoperative chemotherapy. Methods The expression of different biomarkers was examined by immunohistochemistry in 116 primary breast cancers and 65 lymph node metastases. Forty five of these samples were obtained form patients who received preoperative chemotherapy and 71 from untreated patients. Results In primary tumors without preoperative chemotherapy, HIF-1α and Glut-1 were positively correlated (p = 0.02, r = 0.437). HIF-1α in primary and metastatic tumors without preoperative therapy positively correlated with leptin (p < 0.0001, r = 0.532; p = 0.013, r = 0.533, respectively) and ObR (p = 0.002, r = 0.319; p = 0.083, r = 0.387, respectively). Hypoxia markers HIF-1α and Glut-1 were negatively associated with estrogen receptor alpha (ERα) and positively correlated with estrogen receptor beta (ERβ). In this group of tumors, a positive correlation between Glut-1 and proliferation marker Ki-67 (p = 0.017, r = 0.433) was noted. The associations between HIF-1α and Glut-1, HIF-1α and leptin, HIF-1α and ERα as well as Glut-1 and ERβ were lost following preoperative chemotherapy. Conclusions Intratumoral hypoxia in breast cancer is marked by coordinated expression of such markers as HIF-1α, Glut-1, leptin and ObR. The relationships among these proteins can be altered by preoperative chemotherapy. |
Databáze: | OpenAIRE |
Externí odkaz: |